Go Pro
LON:BIOG

The Biotech Growth Trust Interim Earnings Report

The Biotech Growth Trust logo
GBX 1,554 -4.00 (-0.26%)
As of 10:08 AM Eastern

The Biotech Growth Trust EPS Results

Actual EPS
-GBX 1
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

The Biotech Growth Trust Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

The Biotech Growth Trust Announcement Details

Quarter
Interim
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

The Biotech Growth Trust Earnings Headlines

The Biotech Growth Trust PLC - Annual Financial Report
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
See More The Biotech Growth Trust Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like The Biotech Growth Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your email.

About The Biotech Growth Trust

The Biotech Growth Trust (LON:BIOG) seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

View The Biotech Growth Trust Profile